Verily is closing its medical device program as Alphabet shifts more resources to AI

Verily, the life sciences division of Alphabet, is shutting down its medical device program as the company shifts its focus towards artificial intelligence (AI) and data infrastructure. The decision comes as part of a broader restructuring at Alphabet, which aims to consolidate resources and prioritize its investments in AI-driven technologies. The closure of the devices program will result in layoffs, though the exact number of affected employees is not specified in the article. Verily's decision to move away from medical devices reflects the company's strategic shift towards leveraging AI and data-driven solutions to address healthcare challenges. The article suggests that Alphabet, Verily's parent company, is placing a greater emphasis on developing advanced AI capabilities, which are seen as critical to the company's long-term growth and competitiveness. This shift in focus is likely driven by the potential of AI to transform various industries, including healthcare, and Alphabet's desire to maintain its position as a leader in the field of artificial intelligence.